Before reviewing the studies reporting the protection of SCFAs against T1D, it is worth mentioning that the NOD mouse model develops spontaneous diabetes and mimics the situation in the pancreas of patients with respect to the expression of the two major inflammatory cytokines TNF-α and IL-1β and therefore resembles human T1D very well (79). The gene discussed is IL1B; the disease is type 1 diabetes mellitus.